Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Index funds and ETFs each have roles; this note explains when index funds offer a simpler, cost-effective path for many investors.
26,830 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Nasdaq and Talos unveil an industry-scale integration aimed at freeing $35 billion in trapped collateral, linking ris...
Deloitte has crowned NovaScroll as North America’s fastest-growing software company and the private firm is selling p...
A cautionary look at a real-world scam where a fake google support call helped siphon crypto from victim wallets. Lea...
Honeywell Aerospace becomes an independent company after the June 29, 2026 spin-off, offering a focused aerospace exp...
Anthropic has filed a federal lawsuit after being labeled a supply-chain risk by the government, arguing the move thr...
A disappointing sale of 7-year notes underscores investor caution as Iran war fears rise. Traders point to a shifting...
A New York investor turned a $90k oil bet into an $800k windfall, but retirement risk grows as one stock dominates hi...
At the SuperAI Summit in Singapore, Yat Siu laid out a firms-wide thesis that Asia will merge AI and blockchain faste...
When headlines spotlight laura woods’ fiancé adam, it’s easy to overlook the money side of a public dispute. This gui...
Standard Chartered projects stablecoins could generate up to $1 trillion of new US Treasury demand by 2028, signaling...
Meghan Markle headlines a luxury weekend in Sydney, priced like a premium wellness retreat. This deep dive explains w...